LIGAND PHARMACEUTICALS INCORPORATED Proceeds from License Fees Received
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Proceeds from License Fees Received of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLicenseFeesReceived · last filed 2019-02-28
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from license fees received for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from license fees received for fiscal 2017 was $7.05M.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from license fees received for fiscal 2016 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from license fees received for fiscal 2015 was $0.00.
| Period end | Proceeds from License Fees Received 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2017-12-31 | $7.05M 10-K · filed 2019-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |